$6.54
1.24% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Wave Life Sciences Ltd. Stock price

$6.54
+0.42 6.86% 1M
-7.72 54.14% 6M
-5.83 47.13% YTD
+0.16 2.51% 1Y
+5.31 431.71% 3Y
-4.63 41.45% 5Y
-9.46 59.13% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.08 1.24%
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Key metrics

Market capitalization $1.01b
Enterprise Value $796.43m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.59
P/S ratio (TTM) P/S ratio 9.61
P/B ratio (TTM) P/B ratio 5.87
Revenue growth (TTM) Revenue growth -7.06%
Revenue (TTM) Revenue $104.94m
EBIT (operating result TTM) EBIT $-125.75m
Free Cash Flow (TTM) Free Cash Flow $-181.80m
Cash position $243.08m
EPS (TTM) EPS $-0.84
P/E forward negative
P/S forward 16.06
EV/Sales forward 12.69
Short interest 11.77%
Show more

Is Wave Life Sciences Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Wave Life Sciences Ltd. forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy
92%
Hold
8%

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
105 105
7% 7%
100%
- Direct Costs 8.65 8.65
3% 3%
8%
96 96
7% 7%
92%
- Selling and Administrative Expenses 47 47
34% 34%
44%
- Research and Development Expense 167 167
26% 26%
159%
-117 -117
85% 85%
-112%
- Depreciation and Amortization 8.65 8.65
3% 3%
8%
EBIT (Operating Income) EBIT -126 -126
74% 74%
-120%
Net Profit -112 -112
81% 81%
-107%

In millions USD.

Don't miss a Thing! We will send you all news about Wave Life Sciences Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Wave Life Sciences Ltd. Stock News

Neutral
Seeking Alpha
11 days ago
Wave Life Sciences Ltd. (NASDAQ:WVE ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno - President & Chief Executive Officer Erik Ingelsson - Chief Scientific Officer Kyle Moran - Chief Financial Officer Conference Call Participants Joon Lee - Truist Securities Salim Syed - Mizuho Catheri...
Neutral
GlobeNewsWire
13 days ago
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track for 2H 2025 Dosing underway in second single dose cohort (400 mg) and multidosing (200 mg) ongoing in RestorAATion-2 clinical trial of WVE-006 in individuals with PiZZ AATD; data from the complete 2...
Neutral
GlobeNewsWire
20 days ago
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, May 8, 2025, to review the company's first quarter 2025 financial results and provide business updates.
More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office Singapore
CEO Paul Bolno
Employees 288
Founded 2012
Website www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today